Source | fhir.dicom#2023.1.20230123:null (v4.0.1) |
resourceType | ValueSet |
id | dicom-cid-4050-DrugOrContrastAgentCharacteristic |
canonical | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4050.html |
version | 2023.1.20230123 |
status | active |
publisher | NEMA MITA DICOM |
name | DrugorContrastAgentCharacteristic |
date | 2023-01-23 |
experimental | false |
description | Transitive closure of CID 4050 DrugorContrastAgentCharacteristic |
copyright | © 2023 NEMA |
Usages | (none) |
This value set includes codes based on the following rules:
http://dicom.nema.org/resources/ontology/DCM
Code | Display | Definition |
121381 | Contrast/Bolus Ingredient Opaque | X-Ray absorption of the active ingredient of a contrast agent ingredient is greater than the absorption of water (tissue). |
121380 | Active Ingredient Undiluted Concentration | Concentration of the chemically or physically interesting (active) ingredient of a drug or contrast agent as delivered in product form from the manufacturer, typically in mg/ml. |
http://snomed.info/sct
Code | Display |
127489000 | Active Ingredient |
118565006 | Volume |
Produced 06 Apr 2023